UREA BREATH TEST (H. PYLORI)

The UREA BREATH TEST (H. PYLORI) is a non-invasive diagnostic test that detects active Helicobacter pylori infection by measuring urease-driven conversion of administered labelled urea into labelled carbon dioxide in the breath. The test typically uses a safe isotope (commonly 13C) and evaluates the change in breath isotope ratio after ingestion to provide a sensitive and specific result. Available as a lab-at-home service across Dubai and the UAE, it offers convenient sample collection and timely reporting to guide clinical treatment decisions. It is commonly used for initial diagnosis and for confirmation of eradication after therapy, reducing the need for invasive endoscopy in many cases.

• H. pylori infection (Positive / Negative)
• 13C-urea breath test delta over baseline (Δ‰)
• 13CO2 / 12CO2 breath ratio
• Urease activity indicator

• Persistent dyspepsia, epigastric pain or heartburn
• Suspected peptic ulcer disease or gastritis
• Unexplained iron‑deficiency anaemia or chronic gastritis symptoms
• To confirm eradication after H. pylori therapy
• When non‑invasive testing is preferred over endoscopy

• Non‑invasive—no blood draw or invasive procedure required
• High sensitivity and specificity for active infection
• Convenient at‑home collection across Dubai and the UAE
• Rapid results to guide timely treatment decisions
• Suitable for post‑treatment confirmation of eradication

• Fast for at least 4–6 hours prior to the test
• Avoid antibiotics and bismuth for 4 weeks before testing
• Stop proton pump inhibitors (PPIs) at least 2 weeks prior
• Avoid smoking, chewing gum or heavy meals immediately before sample collection